Skip to main content
. 2012 Feb 13;7(2):e30269. doi: 10.1371/journal.pone.0030269

Table 1. Microarray datasets used as training and validation sets.

Contributors Year Set Microarray platform # Patients with ovarian tumor # Patient with high grade, late stage, serous ovarian tumor PMID Source
Bentink et al.[This study] 2011 Training Illumina DASL BeadArray 12k 129 129 E-MTAB-386
Dressman et al. [5] 2007 Validation Affymetrix GeneChip HG-U133A 118 114 17290060 http://data.cgt.duke.edu/platinum.php
Yoshihara et al. [36] 2010 Validation Agilent G4112A 110 43 20300634 GSE17260
Tothill et al. [10] 2008 Validation Affymetrix GeneChip HG-U133A 285 139 18698038 GSE9899
Birrer et al. Bonome et al. [37] 2008 Validation Affymetrix GeneChip HG-U133A 185 185 18593951 GSE26712
TCGATCGA [12] 2011 Validation Affymetrix GeneChip HG-U133A 510 402 21720365 http://tcga-data.nci.nih.gov/tcga/tcgaHome2.jsp
Spentzos et al. [9] 2004 Validation Affymetrix GeneChip HG-U95v2 53 41 15505275 GSE19161
Zhang et al. [38] 2008 Validation Affymetrix GeneChip HG-U133PLUS2 55 46 18458333 GSE19161
Denkert et al. [26] 2009 Validation Affymetrix GeneChip HG-U133A 80 41 19294737 GSE14764
Crijns et al. [39] 2009 Validation Operon human v3 35K 157 85 19192944 GSE13876
Mok et al. [40] 2009 Validation Affymetrix GeneChip HG-U133PLUS2 53 53 19962670 GSE18520